Collectively, our functional assays indicate that rescue of IRF6 and GRHL3 in cancer cell lines has the potential to normalize parts of their tumorigenic phenotype by affecting proliferation, EMT, migration, and differentiation in a tissue-specific manner. Here, IRF6 is linked to cancer.